These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 32243965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G, Nouri K, Grohganz H, Rades T, Löbmann K.
    Int J Pharm; 2017 Nov 25; 533(1):138-144. PubMed ID: 28947246
    [Abstract] [Full Text] [Related]

  • 10. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M, Visti M, Ojarinta R, Laitinen R.
    Eur J Pharm Biopharm; 2018 Aug 25; 129():247-256. PubMed ID: 29894814
    [Abstract] [Full Text] [Related]

  • 11. Co-former selection for co-amorphous drug-amino acid formulations.
    Kasten G, Löbmann K, Grohganz H, Rades T.
    Int J Pharm; 2019 Feb 25; 557():366-373. PubMed ID: 30578980
    [Abstract] [Full Text] [Related]

  • 12. [Co-amorphous technology to improve dissolution and physical stability of silybin].
    Liu H, Zhao GW, Jiang QY, Liang XL, Ouyang LQ, Ding HB, Chen XL, Liao ZG.
    Zhongguo Zhong Yao Za Zhi; 2022 Jan 25; 47(1):103-110. PubMed ID: 35178916
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms.
    Chen J, Li H, Li X, Yuan D, Cheng H, Ke Y, Cheng J, Wang Z, Chen J, Li J.
    Eur J Pharm Biopharm; 2022 Sep 25; 178():82-93. PubMed ID: 35932965
    [Abstract] [Full Text] [Related]

  • 16. A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation.
    Ainurofiq A, Mauludin R, Mudhakir D, Soewandhi SN.
    Pharmaceutics; 2018 Jul 06; 10(3):. PubMed ID: 29986403
    [Abstract] [Full Text] [Related]

  • 17. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K, Sawicki W, Paluch KJ, Tajber L, Grembecka M, Hawelek L, Wojnarowska Z, Grzybowska K, Talik E, Paluch M.
    Eur J Pharm Sci; 2014 Oct 01; 62():132-40. PubMed ID: 24907679
    [Abstract] [Full Text] [Related]

  • 18. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
    Gandhi AV, Thipsay P, Kirthivasan B, Squillante E.
    AAPS PharmSciTech; 2017 Nov 01; 18(8):3140-3150. PubMed ID: 28534299
    [Abstract] [Full Text] [Related]

  • 19. Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement.
    Li W, Song J, Li J, Li M, Tian B, He Z, Liu X, Fu Q.
    Int J Pharm; 2021 Sep 25; 607():120971. PubMed ID: 34363915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.